Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses

v3.4.0.3
Accrued Expenses
3 Months Ended
Mar. 31, 2016
Payables And Accruals [Abstract]  
Accrued Expenses

7.

ACCRUED EXPENSES

Accrued expenses consisted of the following:

 

 

 

March 31,

 

 

December 31,

 

 

 

2016

 

 

2015

 

Accrued clinical operations and trials costs

 

$

1,028,181

 

 

$

365,188

 

Accrued product development costs

 

 

141,756

 

 

 

152,018

 

Accrued audit fees

 

 

60,000

 

 

 

16,500

 

Accrued other

 

 

68,051

 

 

 

28,573

 

Total

 

$

1,297,988

 

 

$

562,279